Dose Escalation Study of Radium-223 Dichloride in Patients With Advanced Skeletal Metastases

NCT01798108 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
31
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bayer